Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor - PubMed (original) (raw)
. 1996 Feb 1;156(3):939-47.
Affiliations
- PMID: 8558020
Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor
C Minshall et al. J Immunol. 1996.
Abstract
Hemopoietic growth factors promote survival of progenitor cells by preventing their apoptotic death. Recently, phosphatidylinositol 3'-kinase (PI 3-kinase) has been shown to be integral in the pathway by which insulin and nerve growth factor prevent apoptosis. In this work, we show that IL-3-dependent FDCP-1/Mac-1 murine hemopoietic progenitors express receptors for another growth factor, insulin-like growth factor-I (IGF-I), and that both IL-3 and IGF-I stimulate PI 3-kinase activity. We then demonstrate that IGF-I shares with IL-3 the properties of significantly promoting proliferation and enhancing survival of myeloid progenitor cells at concentrations as low as 3 ng/ml. IL-3 and IGF-I efficiently promote cell survival in the presence of inhibitors of either RNA synthesis (actinomycin D) or mitosis (mitomycin C), suggesting that both ligands promote survival by a process that is largely independent of RNA synthesis. To determine whether PI 3-kinase mediates IL-3- and IGF-I-induced inhibition of apoptosis, FDCP-1/Mac-1 cells were incubated with the PI 3-kinase inhibitor, wortmannin. While wortmannin inhibited both basal and IGF-I- and IL-3-induced PI 3-kinase enzyme activity, it did not affect the ability of IL-3 to protect FDCP-1/Mac-1 cells from apoptosis, even though it abrogated the IGF-I-induced inhibition of apoptosis. These data demonstrate that even though activation of PI 3-kinase is a pleiotropic feature of both IL-3 and IGF-I receptors in myeloid progenitors, prevention of apoptosis by IL-3 but not IGF-I is independent of PI 3-kinase. Survival of hemopoietic progenitors is therefore maintained by at least two different intracellular signaling pathways, one requiring PI 3-kinase and one that does not.
Similar articles
- Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G, Sailaja D. Chandrasekher G, et al. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3577-88. doi: 10.1167/iovs.04-0279. Invest Ophthalmol Vis Sci. 2004. PMID: 15452065 - IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund GG, Kelley KW. Minshall C, et al. J Immunol. 1997 Aug 1;159(3):1225-32. J Immunol. 1997. PMID: 9233617 - Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging.
Kelley KW, Meier WA, Minshall C, Schacher DH, Liu Q, VanHoy R, Burgess W, Dantzer R. Kelley KW, et al. Ann N Y Acad Sci. 1998 May 1;840:518-24. doi: 10.1111/j.1749-6632.1998.tb09590.x. Ann N Y Acad Sci. 1998. PMID: 9629278 Review. - Growth hormone, growth factors and hematopoiesis.
Kelley KW, Arkins S, Minshall C, Liu Q, Dantzer R. Kelley KW, et al. Horm Res. 1996;45(1-2):38-45. doi: 10.1159/000184757. Horm Res. 1996. PMID: 8742117 Review.
Cited by
- BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.
Amarante-Mendes GP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. Amarante-Mendes GP, et al. Pharmaceutics. 2022 Jan 17;14(1):215. doi: 10.3390/pharmaceutics14010215. Pharmaceutics. 2022. PMID: 35057108 Free PMC article. Review. - CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy.
Brunner-Weinzierl MC, Rudd CE. Brunner-Weinzierl MC, et al. Front Immunol. 2018 Nov 27;9:2737. doi: 10.3389/fimmu.2018.02737. eCollection 2018. Front Immunol. 2018. PMID: 30542345 Free PMC article. Review. - Insulin-like growth factor 1 mitigates hematopoietic toxicity after lethal total body irradiation.
Zhou D, Deoliveira D, Kang Y, Choi SS, Li Z, Chao NJ, Chen BJ. Zhou D, et al. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1141-8. doi: 10.1016/j.ijrobp.2012.08.014. Epub 2012 Sep 25. Int J Radiat Oncol Biol Phys. 2013. PMID: 23021438 Free PMC article. - The inhibitory effect of dibutyryl cyclic AMP on docosahexaenoic acid-induced apoptosis in HL-60 cells through activation of the phosphatidylinositol-3 kinase pathway.
Miura Y, Murata Y, Utsumi K, Takahata K, Tada M, Otsuki T. Miura Y, et al. Environ Health Prev Med. 2005 Jul;10(4):184-9. doi: 10.1007/BF02897709. Environ Health Prev Med. 2005. PMID: 21432138 Free PMC article. - Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates.
Chen BJ, Deoliveira D, Spasojevic I, Sempowski GD, Jiang C, Owzar K, Wang X, Gesty-Palmer D, Cline JM, Bourland JD, Dugan G, Meadows SK, Daher P, Muramoto G, Chute JP, Chao NJ. Chen BJ, et al. PLoS One. 2010 Jun 16;5(6):e11056. doi: 10.1371/journal.pone.0011056. PLoS One. 2010. PMID: 20585403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous